Recombinant Acanthamoeba polyphaga mimivirus Putative transposase R854 (MIMI_R854), partial

Shipped with Ice Packs
In Stock

Description

Genomic Context and Functional Classification

MIMI_R854 is annotated as a transposase, an enzyme responsible for catalyzing the movement of transposable elements (TEs) within genomes. In APMV, transposases are part of a complex genomic landscape shaped by extensive gene duplication and recombination . Key features include:

CharacteristicAPMV Transposase Features
Genome DynamicsAPMV exhibits tandem duplications (e.g., Lcluster with 11-fold duplication) .
Protein FamiliesIncludes BTB/POZ domain-containing proteins (involved in transcriptional regulation) .
Host InteractionPotential disruption of host cytoskeleton or ER membranes during infection .

While MIMI_R854 is not explicitly detailed in published studies, its putative transposase activity aligns with APMV’s reliance on mobile genetic elements to adapt to host environments .

Functional Roles in APMV Biology

Transposases in APMV likely contribute to:

  1. Genome Evolution:

    • Facilitate horizontal gene transfer or genomic rearrangement .

    • Enable adaptation to host immune systems or environmental stressors.

  2. Host Manipulation:

    • Potential involvement in dismantling host cytoskeleton or ER membranes during viral factory formation .

  3. Transcriptional Regulation:

    • Interaction with host or viral transcription factors (e.g., TATA-box-like promoters) .

Research Gaps and Future Directions

Key unanswered questions include:

  • Molecular Mechanism: Does MIMI_R854 act in cis (self-mobilization) or trans (targeting host/other viral genes)?

  • Host Interaction: Does it modulate host pathways for immune evasion or replication?

  • Structural Data: High-resolution crystallography or cryo-EM studies to resolve catalytic domains.

Comparative Analysis of APMV Transposases

APMV’s transposase repertoire contrasts with other NCLDVs (e.g., poxviruses, asfarviruses) but shares functional parallels with bacterial transposons . A hypothetical comparison is outlined below:

Virus/SourceTransposase TypeProposed Function
APMVPutative DDE transposaseGenomic rearrangement, host adaptation .
PoxvirusesNoneN/A
Bacteria (mariner)Himar1C9Random TE insertion for genome evolution .

Recombinant Production and Applications

Recombinant MIMI_R854 is likely generated using:

  1. Cloning: Gateway vectors or PCR-based insertion into expression plasmids .

  2. Purification: Ni-NTA affinity chromatography for His-tagged proteins .

  3. Functional Assays: In vitro transposition activity or host cell co-cultures .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a reference for your consideration.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If you require a specific tag, please inform us, and we will prioritize its implementation.
Synonyms
MIMI_R854Putative transposase R854
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Acanthamoeba polyphaga mimivirus (APMV)
Target Names
MIMI_R854
Uniprot No.

Q&A

Advanced Research Questions

  • How might researchers design experiments to determine if MIMI_R854 participates in APMV genome packaging?

    A comprehensive experimental strategy to investigate MIMI_R854's role in APMV genome packaging would include:

    1. Localization studies:

      • Immunogold electron microscopy using anti-MIMI_R854 antibodies to visualize its location during virion assembly

      • Fluorescently tagged MIMI_R854 to track dynamics during infection using live-cell imaging

      • Co-localization analysis with known packaging components

    2. Interaction mapping:

      • Affinity purification-mass spectrometry to identify protein interactions with packaging machinery

      • Yeast two-hybrid or bacterial two-hybrid screens against viral packaging components

      • In vitro reconstitution of minimal packaging complexes containing purified components

    3. Functional disruption:

      • CRISPR-Cas9 genome editing to generate MIMI_R854-deficient viruses

      • Site-directed mutagenesis of catalytic residues to distinguish enzymatic from structural roles

      • Complementation assays with wild-type or mutant proteins

    4. DNA interaction studies:

      • ChIP-seq to map genome-wide binding of MIMI_R854 during infection

      • DNase footprinting to identify protected regions and binding motifs

      • In vitro analysis of DNA structure alterations induced by MIMI_R854

    These approaches would reveal whether MIMI_R854 functions within the context of APMV's unique genome segregation and packaging system, which notably includes components reminiscent of prokaryotic chromosome segregation machinery .

  • What role might MIMI_R854 play in the horizontal gene transfer capabilities of APMV?

    MIMI_R854 may facilitate horizontal gene transfer (HGT) through several mechanisms:

    • Creation of recombination hotspots: Transposase-induced DNA breaks can serve as entry points for foreign DNA

    • Mobilization of genomic segments: Catalyzing movement of viral gene cassettes during co-infection scenarios

    • Integration of foreign DNA: Potential role in capturing and integrating environmental DNA

    • Genome plasticity enhancement: Generating insertions, deletions, and rearrangements that create evolutionary advantages

    Experimental approaches to study these functions include:

    1. Co-infection models: Tracking gene flow between viral strains in the presence/absence of functional MIMI_R854

    2. Metagenomic analysis: Identifying foreign gene signatures and integration patterns near transposase recognition sites

    3. In vitro transposition with heterologous substrates: Testing ability to mobilize diverse DNA sources

    4. Long-term evolution experiments: Comparing genomic acquisition rates between wild-type and MIMI_R854-deficient viruses

    The significant proportion of APMV genes with apparent prokaryotic, archaeal, and eukaryotic origins strongly suggests that mechanisms for genetic material acquisition, potentially including transposase-mediated HGT, have been central to the evolution of this giant virus .

  • How can researchers resolve contradictory findings regarding MIMI_R854 activity?

    Resolving contradictions in experimental findings requires systematic investigation of variables that might affect MIMI_R854 activity:

    1. Protein preparation standardization:

      • Compare multiple expression systems and purification methods

      • Verify protein integrity through biophysical techniques (CD spectroscopy, SEC-MALS)

      • Quantify aggregation states and post-translational modifications

    2. Comprehensive condition optimization:

      ParameterRange to testMethods
      pH5.0-9.0Buffer series with constant ionic strength
      Temperature4-42°CThermostatically controlled reactions
      Divalent cationsMg²⁺, Mn²⁺, Ca²⁺Titration experiments
      Salt concentration0-500 mMNaCl or KCl gradients
      Redox environmentReducing/oxidizingDTT or H₂O₂ addition
    3. Substrate diversity assessment:

      • Test various DNA structures (linear, circular, supercoiled)

      • Examine sequence preferences through systematic variation

      • Compare activity on host versus viral DNA substrates

    4. Protein interaction effects:

      • Supplement with cellular extracts from different sources

      • Add candidate cofactors (nucleoid-associated proteins, chaperones)

      • Test dependence on DNA-binding proteins from APMV

    5. Alternative activity screening:

      • Expand beyond traditional transposition to test for nuclease, helicase, or recombinase activities

      • Examine potential regulatory roles independent of catalytic function

    This systematic approach not only resolves contradictions but often leads to deeper mechanistic understanding and biological context for enzymatic activity .

  • What bioinformatic approaches can identify potential MIMI_R854 target sequences within the APMV genome?

    A multi-layered computational strategy for target sequence identification includes:

    1. Sequence motif discovery:

      • Multiple alignment of known transposase binding sites from related enzymes

      • Application of motif discovery tools (MEME, GLAM2) to identify consensus elements

      • Position weight matrix (PWM) development and genome scanning

    2. Structural feature analysis:

      • DNA shape and deformability prediction using tools like DNAshape

      • Assessment of intrinsic curvature and flexibility parameters

      • Identification of unusual DNA structures (cruciforms, G-quadruplexes)

    3. Comparative genomics:

      • Analysis of insertion site patterns across multiple APMV isolates

      • Identification of conserved non-coding regions as potential targets

      • Detection of genomic islands with evidence of past mobility

    4. Machine learning integration:

      • Feature extraction from known transposase targets

      • Supervised learning using random forests or neural networks

      • Genome-wide prediction with confidence scoring

    5. Experimental data correlation:

      • Integration with RNA-seq data to identify potential regulatory relationships

      • Correlation with viral DNA replication timing

      • Validation of high-confidence predictions through in vitro binding assays

    This comprehensive approach yields a ranked list of potential target sites that can be experimentally verified through methods such as ChIP-seq or in vitro binding assays.

  • How might MIMI_R854 contribute to APMV's adaptation to different host environments?

    MIMI_R854 could facilitate host adaptation through several mechanisms:

    • Genomic plasticity: Generating structural variations that enable rapid adaptation to new hosts

    • Regulatory network rewiring: Creating new gene regulatory connections through insertions near promoters

    • Gene acquisition: Facilitating incorporation of host genes that enhance viral fitness

    • Immune evasion: Generating antigenic diversity through gene disruption or rearrangement

    Experimental approaches to investigate these functions:

    1. Experimental evolution:

      • Serial passage of APMV in different Acanthamoeba species or other potential hosts

      • Comparative genomics between ancestral and adapted strains

      • Functional validation of observed genomic changes

    2. Transcriptomic profiling:

      • RNA-seq analysis of host and viral gene expression during infection

      • Identification of differentially regulated pathways in different hosts

      • Correlation with genomic positions of MIMI_R854 activity

    3. Fitness measurements:

      • Competition assays between wild-type and MIMI_R854-deficient viruses

      • Replication kinetics in various host backgrounds

      • Measurement of virion production and infectivity

    These approaches can reveal how MIMI_R854-mediated genomic plasticity contributes to the remarkable adaptability of giant viruses across different environments .

  • What role might MIMI_R854 play in APMV's complex genome organization and regulation?

    MIMI_R854 could influence genome organization and regulation through:

    • Chromatin-like structure formation: Potential role in organizing viral DNA within the nucleoid-like core

    • Genome segmentation: Creating functional domains through sequence-specific binding

    • Regulatory element positioning: Mobilizing enhancers or silencers to modulate gene expression

    • DNA topology management: Influencing local DNA supercoiling or higher-order structure

    Research approaches to explore these functions:

    1. Chromatin immunoprecipitation sequencing (ChIP-seq):

      • Genome-wide mapping of MIMI_R854 binding sites during infection

      • Integration with transcriptomic data to correlate binding with gene expression

      • Time-course analysis to track dynamic interactions

    2. Chromosome conformation capture (3C/Hi-C):

      • Mapping three-dimensional interactions within the viral genome

      • Comparison between wild-type and MIMI_R854-deficient viruses

      • Identification of topologically associated domains

    3. DNA accessibility mapping:

      • ATAC-seq to identify open chromatin regions influenced by MIMI_R854

      • DNase-seq to map hypersensitive sites and protected regions

      • Correlation with transcriptional activity and replication timing

    APMV's complex genome organization, with genes involved in protein translation and DNA replication, makes these regulatory functions particularly significant . The presence of genes encoding proteins typically found in cellular organisms suggests sophisticated regulatory mechanisms beyond those of typical viruses.

  • How can CRISPR-Cas9 be applied to investigate MIMI_R854 function in APMV?

    CRISPR-Cas9 offers powerful approaches for MIMI_R854 functional studies:

    1. Gene knockout strategies:

      • Complete deletion using dual guides flanking MIMI_R854

      • Disruption through frameshift mutations

      • Conditional knockout systems for essential functions

    2. Domain-specific modifications:

      • Precise mutation of catalytic residues (DDE/D motif)

      • Tag insertion for localization and interaction studies

      • Promoter modifications to alter expression levels

    3. Experimental protocol:

      StepMethodConsiderations
      gRNA designTarget unique sequences with minimal off-targetsAPMV's AT-rich genome requires careful specificity analysis
      DeliveryTransfection of Cas9-gRNA RNPs into infected cellsTiming relative to infection cycle is critical
      Editing verificationPCR, sequencing, Western blottingConfirm both genomic changes and protein alterations
      Viral isolationPlaque purification or limiting dilutionMultiple rounds may be needed for clonal populations
      Phenotypic analysisReplication kinetics, transcriptomics, microscopyComprehensive characterization across infection cycle
    4. Advanced applications:

      • Base editing for introducing point mutations without double-strand breaks

      • CRISPRi for transient downregulation without permanent modification

      • Prime editing for precise sequence replacements

    These approaches enable detailed investigation of MIMI_R854's role in APMV's complex life cycle, including potential functions in genome packaging suggested by its relationship to components of the viral packaging machinery, which notably includes elements reminiscent of prokaryotic chromosome segregation systems .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.